25,995 Shares in Azenta, Inc. $AZTA Acquired by CenterBook Partners LP

CenterBook Partners LP purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 25,995 shares of the company’s stock, valued at approximately $865,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Assetmark Inc. lifted its position in Azenta by 54.1% during the 4th quarter. Assetmark Inc. now owns 832 shares of the company’s stock worth $28,000 after acquiring an additional 292 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Azenta by 249.5% in the 3rd quarter. Bessemer Group Inc. now owns 1,017 shares of the company’s stock valued at $29,000 after purchasing an additional 726 shares in the last quarter. Osaic Holdings Inc. raised its position in shares of Azenta by 44.9% in the 2nd quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock valued at $39,000 after purchasing an additional 385 shares in the last quarter. Quantbot Technologies LP acquired a new position in shares of Azenta in the 3rd quarter valued at approximately $57,000. Finally, CWM LLC raised its position in shares of Azenta by 27.3% in the 4th quarter. CWM LLC now owns 1,822 shares of the company’s stock valued at $61,000 after purchasing an additional 391 shares in the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Needham & Company LLC cut their target price on Azenta from $44.00 to $33.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 18th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Azenta presently has a consensus rating of “Hold” and an average target price of $39.50.

Azenta Price Performance

AZTA stock opened at $22.38 on Thursday. Azenta, Inc. has a 1-year low of $15.93 and a 1-year high of $41.73. The firm has a fifty day moving average price of $21.95 and a two-hundred day moving average price of $28.33. The firm has a market cap of $1.03 billion, a price-to-earnings ratio of -5.65 and a beta of 1.39.

Azenta (NASDAQ:AZTA) last released its earnings results on Wednesday, May 6th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.16). Azenta had a negative net margin of 30.49% and a positive return on equity of 1.23%. The business had revenue of $144.80 million for the quarter, compared to the consensus estimate of $148.47 million. During the same quarter in the previous year, the firm earned $0.01 EPS. The firm’s revenue for the quarter was up 1.4% on a year-over-year basis.

About Azenta

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end?to?end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next?generation sequencing (NGS), DNA synthesis, and molecular biology services.